Supriya Rao, MD, is a board-certified physician in internal medicine, gastroenterology, obesity medicine, and lifestyle medicine
Yes, GLP-1 medications can be used by individuals with PCOS and PMDD, as they help regulate appetite, support weight loss, and stabilize blood sugar levels, which can improve symptoms of both conditions
People often start Ozempic, for example, with 0.25 mg weekly and slowly move up to 0.5 mg or even 1 mg or 2 mg
40 mg/mL: the ultra-concentrated formulation At 40 mg/mL, 10 units delivers a full 4.0 mg of tirzepatide
In humans, one study reported that GLP-1R gene expression in the dlPFC was significantly different between healthy controls and mood disorder patients after controlling for age, sex, ethnicity, and BMI (Mansur et al., 2015b)
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis